1 month Oppenheimer Cuts Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $350.00MarketBeat
Oppenheimer cut their price target on shares of Madrigal Pharmaceuticals from $375.00 to $350.00 and set an “outperform” rating for the company in a report on Wednesday.
X